[IPO Registration Approval Progress Weekly](Week 35) Last week, Yulong Technology's registration came into effect and Tiangui's registration submission process accelerated

★ Disclaimer: This article is an objective compilation of public information and does not constitute any investment advice or securities recommendation ★

1. Overview of registration approvals last week

According to statistics from the Prospective Industry Research Institute, the main progress of the registration process in the 35th week of 2026 (August 24-August 30) is as follows:

Yulong Technology (Chongqing Yulong Optoelectronics Technology Co., Ltd., GEM) was approved by the China Securities Regulatory Commission for registration on August 28 and the registration took effect. It was only about 22 days from the exchange's approval on August 6 to the registration took effect. The registration process is advancing rapidly;

Tianguangshi (Beijing Tianguangshi Biotechnology Co., Ltd., Beijing Stock Exchange) changed its IPO review status from "approved" to "submitted for registration" on August 24.

Overall, last week's registration approval continued the normalized pace of the 34th week (the registrations of Huahui Intelligent and Qiqiqi Intelligent came into effect), and the registration efficiency was further improved.

2. Registered enterprise: Yulong Technology (GEM)

Chongqing Yulong Optoelectronics Technology Co., Ltd. focuses on the research and development, production and sales of smart control cards and precision functional device-related products in the field of new semiconductor display panels. The products are mainly used in LCD display panels. The company plans to be listed on the GEM of the Shenzhen Stock Exchange. The sponsor institution is CITIC Securities Co., Ltd., and plans to raise approximately 1 billion yuan.

According to the prospectus, Yulong Technology's revenue from BOE in 2023-2025 accounted for 79.10%, 53.61% and 55.22% respectively, and the top five customers accounted for 94.28%, 93.45% and 94.66% respectively. Customer concentration is high.

3. Enterprise submitted for registration: Tianguangshi (Beijing Stock Exchange)

Beijing Tianguoshi Biotechnology Co., Ltd. is a biopharmaceutical company focusing on the research and development and industrialization of innovative antibody drugs. The core product, Beijiexin ® (Otozumab Beta Injection), has been approved for marketing in China. It is used in the treatment of optic neuromyelitis spectrum diseases (NMOSD) and primary membranous nephropathy (pMN). The company is a national-level high-tech enterprise and a specialized and innovative small and medium-sized enterprise in Beijing City. On August 24, 2026, the IPO review status of the company's Beijing Stock Exchange was changed from "approved" to "submitted for registration", and will subsequently be submitted to the China Securities Regulatory Commission to perform the registration procedures.

4. Observation of the rhythm of registration approval

Last week, the registration process showed a two-line advancement of "one effective company, one submitted": the efficient registration of Yulong Technology came into effect, reflecting the regulatory support for hard technology companies such as semiconductor displays; Tianguoshi submitted the registration, which opened up space for subsequent issuance of biomedical targets. Combined with the fact that two registrations took effect in the 34th week, the registration approvals have maintained a normal pace of about two registrations per week in the past two weeks, and the registration cycle has been significantly shortened, which will help relieve queuing pressure and improve financing efficiency. In the future, we need to pay attention to the issuance arrangements of Yulong Technology and the progress of Tianguang's registration.

★ Data sources and disclaimers ★

Disclaimer: This article is an objective compilation of public information and does not constitute any investment advice or securities recommendation

Data source: This article is based on public review developments of the Shanghai and Shenzhen Stock Exchanges, announcements of the China Securities Regulatory Commission, and public disclosure information such as prospectuses and issuance announcements of various companies. If there is any difference between the content of this article and the final official disclosure, the official announcement of the exchange and the issuer shall prevail.

Report produced by: Prospective Industry Research Institute

★ About the Prospective Industry Research Institute ★

The Prospective Industry Research Institute was established in 1998 and is headquartered in Shenzhen and has professional research centers in Beijing, Hangzhou, Chengdu and other places. Prospective is the earliest technology-based think tank in China focusing on industrial big data and IPO consulting, and is also the current leader in the research field of domestic IPO market segments. Based on the data cited in the prospectus of companies and listed companies that have successfully participated in meetings over the years, the Prospective Industry Research Institute has been the leading market share consultant for IPO industry research and feasibility research of fundraising projects for many consecutive years.

Prospective mainly provides professional IPO consulting services, refinancing consulting services and M & A consulting services to companies planning to be listed and listed companies. Specific contents include: A-share IPO market segment research (in-depth support for the "Business and Technology" chapter of the prospectus), feasibility study of IPO fundraising projects, feasibility study of refinancing fundraising projects (additional issuance, convertible bonds), due diligence and feasibility study of M & A targets, Hong Kong stock IPO industry consultant, commercial due diligence, post-investment project management evaluation, etc.

As of 2026, the Prospective Industry Research Institute has successfully provided IPO consulting services to more than 1200 companies, and its professional data has been cited in more than 8000 listing documents. Serving customers comprehensively covers major industries such as new generation information technology, biomedicine, high-end equipment manufacturing, new materials, new energy, energy conservation and environmental protection, and TMT.

Prospective is a consulting company with big data heritage and industry depth. Business consulting: 400-639-9936, 150-1360-1266

If you quote the data of this article in the prospectus or the company's annual report, please contact the Prospective Industry Research Institute at 400-068-7188.

Forward-looking Economist

Prospective Industry Research Institute is a leader in industrial consulting in China, specializing in providing solutions in industrial planning, industrial declaration, industrial upgrading and transformation, industrial park planning, feasibility reports and other fields to sweep away attention. Related reading RELEVANT [IPO Weekly Report_Registration Approval Progress] Last week, two companies obtained registration approvals, and Shengu Group made 2.1 billion yuan on the main board of Shanghai Stock Exchange.

[IPO Registration Approval Progress] Two companies obtained registration approvals last week, and Huahui Intelligent and Qiqiqi Intelligent received approvals (week 34 of 2026)

[August 31 IPO Observation] Week 36 (forecast) Suiyuan Technology Subscription, Week 35 (resumption) Jiahong/Changde Conference, 5 subscriptions, Suxun New Materials Conference

[Announcement for IPO this week] Only one IPO will be held on the Beijing Stock Exchange this week (Suxun Xincai, 8-28) All five companies in the previous period will be held on the Beijing Stock Exchange

[August 28 IPO Observation Morning Post] This week (8.24-8.30), 5 subscriptions and 1 company appeared, and the issuance pace slowed down significantly compared with last week

[Observation on IPO dynamics on August 11] Ultra-pure materials surged 662% on the first day! Three new shares listed on the same day collectively rose sharply, and Tianguishi held three IPOs

This article explores Aromatherapy, fragrance, perfume, essential oil, non-fire aroma, aroma candle, rattan aroma, home aroma, natural aroma, diffuser, sharing the latest industry insights and offering practical references for enthusiasts.

Source: 前瞻产业研究院 (https://www.qianzhan.com/)

This article is reproduced from the original source for information sharing only. If it infringes any copyright, please contact us and we will remove it promptly.

© 2026 CeresMall | www.CeresMall.com